Department

Norton Rose Fulbright grows in Chicago with seven projects-focused real estate lawyers from Clean Law PC

Retrieved on: 
Monday, August 15, 2022 - 4:05pm

Jeff Cody, Norton Rose Fulbrights US Managing Partner, said:

Key Points: 
  • Jeff Cody, Norton Rose Fulbrights US Managing Partner, said:
    Projects and real estate are two cornerstones of Norton Rose Fulbrights business practice, which we have prioritized as a growth area for the firm.
  • Young, who founded Clean Law PC in 2017, said:
    I am delighted to join Norton Rose Fulbright, which advises on some of the most significant real estate and projects deals in the world.
  • Global law firm Norton Rose Fulbright provides the worlds preeminent corporations and financial institutions with a full business law service.
  • Norton Rose Fulbright Verein, a Swiss verein, helps coordinate the activities of Norton Rose Fulbright members but does not itself provide legal services to clients.

FAFSA® Completion Rates Stabilizing but Three-Quarters of Families Unaware It’s Available on October 1, According to “How America Pays for College 2022”

Retrieved on: 
Monday, August 15, 2022 - 4:07pm

The good news is FAFSA completion rates seem to be holding steady although wed love to see those rates even higher.

Key Points: 
  • The good news is FAFSA completion rates seem to be holding steady although wed love to see those rates even higher.
  • Families reported spending $25,313, on average, on college expenses in academic year 2021-22 with 87% relying on income and savings to cover 54% of college expenses.
  • Families agree college is an investment in the students future (88%) and earning a college degree will create more opportunities (88%).
  • College students and their families are prioritizing the experiences and social aspects of college that they may feel like they have been missing.

JBS Announces Key Leadership Changes

Retrieved on: 
Monday, August 15, 2022 - 4:04pm

GREELEY, Colo., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Three JBS executives are transitioning to new leadership roles within the company, resulting from internal promotions.

Key Points: 
  • GREELEY, Colo., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Three JBS executives are transitioning to new leadership roles within the company, resulting from internal promotions.
  • Michael Koenig has been named Global Chief Ethics and Compliance Officer of JBS.
  • Machados 27-year career has included nearly 15 years spent with JBS in a variety of financial leadership roles including CFO, investor relations officer, and director of financial planning and analysis.
  • Machado will be based in Greeley, Colo.
    Michael, Denilson and Victor have established themselves as standout leaders during their time with JBS and throughout their careers, said Tim Schellpeper, JBS USA CEO.

Connecticut Innovations Launches VentureClash Climate Edition

Retrieved on: 
Monday, August 15, 2022 - 2:00pm

NEW HAVEN, Conn., Aug. 15, 2022 /PRNewswire-PRWeb/ -- Connecticut Innovations (CI), along with Connecticut Green Bank, the Department of Economic & Community Development, the Connecticut Department of Energy and Environmental Protection, and the Connecticut Public Utilities Regulatory Authority, today announced the launch of VentureClash Climate Edition, a networking and pitch event that brings together companies and thought leaders solving real-world climate issues.

Key Points: 
  • NEW HAVEN, Conn., Aug. 15, 2022 /PRNewswire-PRWeb/ -- Connecticut Innovations (CI), along with Connecticut Green Bank, the Department of Economic & Community Development, the Connecticut Department of Energy and Environmental Protection, and the Connecticut Public Utilities Regulatory Authority, today announced the launch of VentureClash Climate Edition, a networking and pitch event that brings together companies and thought leaders solving real-world climate issues.
  • "The launch of VentureClash Climate Edition coincides with the launch of our newest ClimateTech Fund, which will put $100 million of capital to work," said Konstantine Drakonakis, fund manager of Connecticut Innovations' ClimateTech Fund.
  • VentureClash Climate Edition is looking for international and domestic companies interested in building a presence in Connecticut that offer solutions across, but not limited to, four main industry sectors: energy, water, waste and mobility.
  • Managed by Connecticut Innovations, VentureClash scans the globe for early-stage companies that are looking to land and expand in Connecticut.

Flu Shots Are Now Available at Walgreens Nationwide for Everyone Aged 3 and Up

Retrieved on: 
Monday, August 15, 2022 - 2:00pm

Walgreens is now offering flu shots for anyone aged 3 years and up at nearly 9,000 store locations nationwide to help reduce the spread of vaccine-preventable illnesses in communities.

Key Points: 
  • Walgreens is now offering flu shots for anyone aged 3 years and up at nearly 9,000 store locations nationwide to help reduce the spread of vaccine-preventable illnesses in communities.
  • To help save families a trip, Walgreens pharmacists are co-administering flu shots and other recommended vaccines during a single visit.
  • Walgreens is offering a $5 Walgreens Cash reward in August through December and a $10 Walgreens Cash reward* during the month of September to individuals who receive any vaccination at a Walgreens location.
  • To schedule an appointment for a flu shot or any vaccine at Walgreens, please visit Walgreens.com/ScheduleVaccine or download the Walgreens app.

AEye Announces Partnership With Booz Allen Hamilton to Advance Software-Defined Lidar in Aerospace and Defense Applications

Retrieved on: 
Monday, August 15, 2022 - 1:30pm

Aerospace and defense applications must be able to see, classify, and respond to an object in real time, at high speeds, and at long distances.

Key Points: 
  • Aerospace and defense applications must be able to see, classify, and respond to an object in real time, at high speeds, and at long distances.
  • We are collaborating with Booz Allen Hamilton to optimize its real-time embedded processor perception stack.
  • Booz Allen will enable AEyes adaptive, software-defined architecture that greatly expands the utility of AI and ML for defense applications, which we believe will be a game-changer.
  • These are all critical requirements for aerospace and defense, and cornerstones in the designs that we build at AEye.

Outset Medical Awarded VA Contract Aimed at Improving Dialysis Care for Veterans

Retrieved on: 
Monday, August 15, 2022 - 2:00pm

Outset Medical, Inc. (Nasdaq: OM) (Outset) announced today that the Strategic Acquisition Center (SAC) Office of Procurement, Department of Veterans Affairs awarded a national contract that enables the companys Tablo Hemodialysis System to be sold into the 106 VA hospitals in the U.S.

Key Points: 
  • Outset Medical, Inc. (Nasdaq: OM) (Outset) announced today that the Strategic Acquisition Center (SAC) Office of Procurement, Department of Veterans Affairs awarded a national contract that enables the companys Tablo Hemodialysis System to be sold into the 106 VA hospitals in the U.S.
    VA medical facilities across the U.S. provide dialysis care for 35,000 veterans.
  • Our honored veterans deserve to have the most advanced dialysis care possible, and it is our great privilege to support them through the SAC contract for hemodialysis care, said Leslie Trigg, Chair and Chief Executive Officer of Outset.
  • This partnership with the VA will further our mission to bring a technology-enabled, patient-centered approach to dialysis both in the acute and home setting.
  • Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.

Avails Medical announces the commencement of U.S. Pivotal Clinical Trials for eQUANT™

Retrieved on: 
Monday, August 15, 2022 - 1:00pm

MENLO PARK, Calif., Aug. 15, 2022 /PRNewswire/ -- Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST) announced today the commencement of U.S. pivotal clinical trials for its eQUANTsystem, which will be used to support a submission for FDA clearance.

Key Points: 
  • MENLO PARK, Calif., Aug. 15, 2022 /PRNewswire/ -- Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST) announced today the commencement of U.S. pivotal clinical trials for its eQUANTsystem, which will be used to support a submission for FDA clearance.
  • In a recent clinical pilot study Avails demonstrated highly accurate AST results when using the eQUANT McFarland output.
  • "Our modular, cost-efficient eQUANT system features a small footprint and straight-forward user interface, making it well suited for widespread adoption from clinical laboratories to community hospitals.
  • Avails Medical, Inc., a privately held company, was founded to help fight one of today's biggest global health threats - antibiotic resistance.

Regenative Labs announces groundbreaking Wharton's Jelly research demonstrating HCT/P compliance after processing

Retrieved on: 
Monday, August 15, 2022 - 1:00pm

PENSACOLA, Fla., Aug. 15, 2022 /PRNewswire/ -- Regenative Labs, a leading HCT/P manufacturer, has co-authored a pioneering paper together with experts from The Institute of Regenative Medicine and the Department of Pharmacology and Chemical Biology, Baylor College of Medicine.

Key Points: 
  • Regenative Labs has pioneered the use of perinatal tissue allografts and is pleased that this paper supports our current homologous use practices, consistent with our 361 status.
  • About Regenative Labs: Regenative Labs produces regenerative medicine products to address the root cause of a patient's conditions using Wharton's Jelly innovations rather than masking the pain with other treatments.
  • Regenative Labs works closely with scientists, physicians, hospitals, and surgery centers to constantly monitor and improve patient progress and outcomes for new product development.
  • Regenative Labs's expert product research and development team compliesFDA guidelines of minimal manipulation for homologous use.

ASTERRA's new satellite based PolSAR technology uses AI for eco-friendly exploration of lithium

Retrieved on: 
Monday, August 15, 2022 - 12:00pm

TEL AVIV, Israel, Aug. 15, 2022 /PRNewswire/ -- Today, ASTERRA announced a patent filing on advancements in using PolSAR-based technology for lithium exploration that will greatly accelerate the identification of lithium (LI) deposits. The patent was based on extensive field testing for validation. 

Key Points: 
  • TEL AVIV, Israel, Aug. 15, 2022 /PRNewswire/ -- Today, ASTERRA announced a patent filing on advancements in using PolSAR-based technology for lithium exploration that will greatly accelerate the identification of lithium (LI) deposits.
  • "The expansion to mining is a natural progression of our ability to use AI analytics to monitor soil moisture underground," said Elly Perets, CEO of ASTERRA.
  • ASTERRA's complex artificial intelligence (AI) and machine learning (ML) algorithms extract the signal of lithium concentration underground from satellite based PolSAR data and can pinpoint locations containing high lithium.
  • This technology creates a way to find lithium before investing in costly exploration with intensive labor, and where it may result in environmental destruction and civil conflicts.